FDA Inspection 1141689 — Mark Roschewski, M.D.

Mark Roschewski, M.D. — FEI 3018118045

The FDA completed an inspection of Mark Roschewski, M.D. on May 11, 2021 in Bethesda, MD. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 11, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bethesda, MD (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance